Elacestrant, sold under the brand name Orserdu, is an anticancer medication. it is an estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. Reference standards of Elacestrant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Elacestrant - API standards [catalogue_number] => PA 05 2150000 [category_ids] => ,78,70,82, [chemical_name] => [weight] => 458.65 [form] => C30H38N2O2 [cas] => 722533-56-4 [pslug] => 722533-56-4-elacestrant-api-standards-pa052150000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 05 2150000
CAS :
Molecular Formula : C30H38N2O2
Molecular Weight : 458.65
stdClass Object ( [pname] => (S)-Elacestrant Dihydrochloride [catalogue_number] => PA 05 2151000 [category_ids] => ,78,70,82, [chemical_name] => [weight] => 531.56 [form] => C30H40Cl2N2O2 [cas] => 2309762-30-7 [pslug] => 2309762-30-7-s-elacestrant-dihydrochloride-pa052151000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 05 2151000
Molecular Formula : C30H40Cl2N2O2
Molecular Weight : 531.56
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
